Suchergebnisse - "Sarah Louise Duus Holle"

The prognostic value of neurohormonal and inflammatory biomarkers in addition to the TIMI risk score in patients with ST-elevation myocardial infarction.

Autoren: Duus Holle, Sarah Louise Søholm, Helle Møller, Jacob Eifer et al.

Quelle: Biomarkers; Feb2025, Vol. 30 Issue 1, p1-9, 9p

Schlagwörter: DISEASE risk factors, ST elevation myocardial infarction, PROPORTIONAL hazards models, MYOCARDIAL infarction, PROGNOSIS

Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial

Autoren: Kunkel, Joakim Bo Holle, Sarah Louise Duus Hassager, Christian et al.

Quelle: Trials; 11/5/2024, Vol. 25 Issue 1, p1-12, 12p

Schlagwörter: CARDIAC magnetic resonance imaging, MYOCARDIAL infarction, DISEASE risk factors, CARDIOGENIC shock, INTERLEUKIN-6 receptors

Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial.

Autoren: Holle, Sarah Louise Duus Kunkel, Joakim Bo Hassager, Christian et al.

Quelle: Trials; 10/30/2024, Vol. 25 Issue 1, p1-12, 12p

Schlagwörter: MYOCARDIAL infarction, CARDIOGENIC shock, DISEASE risk factors, PERCUTANEOUS coronary intervention, CREATINE kinase